Mount Yale Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-179
Closed -$22.3K – 1401
2025
Q2
$22.3K Buy
+179
New +$22.8K ﹤0.01% 1023
2019
Q3
– Sell
-2,245
Closed -$202K – 330
2019
Q2
$202K Buy
+2,245
New +$153K 0.04% 291
2018
Q4
– Sell
-1,290
Closed -$88K – 671
2018
Q3
$88K Buy
1,290
+33
+3% +$1.7K 0.02% 481
2018
Q2
$59K Buy
1,257
+861
+217% +$35.4K 0.01% 601
2018
Q1
$14K Buy
+396
New +$13.9K ﹤0.01% 822

Other funds holding RGEN

Mount Yale Investment Advisors's RGEN Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of Repligen (RGEN) in Q3 2025, closing a stake of 179 shares — an estimated $22.3K sold.

Mount Yale Investment Advisors first reported a position in RGEN in Q1 2018 and held it in 5 quarters. The position peaked at $202K in Q2 2019. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Mount Yale Investment Advisors reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 179 Repligen shares in Q3 2025, an estimated $22.3K.
  • Mount Yale Investment Advisors first reported a position in Repligen in Q1 2018 and held it in 5 quarters.
  • Mount Yale Investment Advisors's Repligen position peaked at $202K in Q2 2019.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.